Does modified radical mastectomy in de novo stage IV inflammatory breast cancer patients improve disease specific survival?

被引：0
|
作者：
Chen, J. C.
Li, Yaming
Fisher, James L.
Tsung, Allan
Obeng-Gyasi, Samilia
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P1-24-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-24-01
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Locoregional Treatment of the Primary Tumor Shows Survival Benefit in De Novo Stage IV Breast Cancer
    Choi, S.
    Rhee, W. J.
    Kim, T. H.
    Kim, J. W.
    Suh, C. O.
    Keum, K. C.
    Lee, I. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E10 - E10
  • [32] Locoregional Treatment of the Primary Tumor Shows Survival Benefit in De Novo Stage IV Breast Cancer
    Choi, S. H.
    Rhee, W. J.
    Kim, J. W.
    Suh, C. O.
    Keum, K. C.
    Kim, Y. B.
    Lee, I. J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S339 - S339
  • [33] A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer
    Kommalapati, Anuhya
    Tella, Harsha
    Goyal, Gaurav
    Ganti, Apar Kishor
    Krishnamurthy, Jairam
    Tandra, Pavan Kumar
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (03) : 677 - 685
  • [34] Genomic landscape of de novo stage IV breast cancer.
    Garrido-Castro, Ana Christina
    Spurr, Liam
    Hughes, Melissa E.
    Li, Yvonne Y.
    Cherniack, Andrew D.
    Bychkovsky, Brittany L.
    Barroso-Sousa, Romualdo
    Di Lascio, Simona
    Files, Janet
    Kumari, Priti
    Cerami, Ethan
    Krop, Ian E.
    MacConaill, Laura E.
    Lindeman, Neal Ian
    Rollins, Barrett J.
    Johnson, Bruce E.
    Wagle, Nikhil
    Winer, Eric P.
    Dillon, Deborah
    Lin, Nancy U.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] The tumor-to-breast volume ratio (TBR) predicts cancer-specific survival in breast cancer patients who underwent modified radical mastectomy
    Wen, Jiahuai
    Ye, Feng
    Huang, Xiaojia
    Li, Shuaijie
    Yang, Lu
    Xiao, Xiangsheng
    Xie, Xiaoming
    [J]. TUMOR BIOLOGY, 2016, 37 (06) : 7493 - 7500
  • [36] Role of Locoregional Treatment in De Novo Stage IV Breast Cancer
    Lee, Joanna S.
    Toktas, Osman
    Soran, Atilla
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2020, 14
  • [37] A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer
    Anuhya Kommalapati
    Sri Harsha Tella
    Gaurav Goyal
    Apar Kishor Ganti
    Jairam Krishnamurthy
    Pavan Kumar Tandra
    [J]. Breast Cancer Research and Treatment, 2018, 170 : 677 - 685
  • [38] Stereotactic radiotherapy to primary breast cancer in de novo stage IV disease: preliminary results
    Ippolito, E.
    Silipigni, S.
    Matteucci, P.
    Carrafiello, S.
    Fiore, M.
    Greco, C.
    Di Donato, A.
    Palumbo, V.
    Tacconi, C.
    Ramella, S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1005 - S1006
  • [39] CHARACTERISTICS OF DE NOVO STAGE IV BREAST CANCER PRESENTATION AND COMPARISON WITH STAGE IV DISEASE RELAPSE AFTER ADJUVANT THERAPY
    Waynick, C.
    Romond, E.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 408 - 408
  • [40] Comparison of survival between de novo stage IV and recurrent stage IV gastric cancer.
    Ji, Jun Ho
    Lee, Danbi
    Lee, Yong-Pyo
    Huh, Seok Jae
    Go, Se-Il
    Kim, Jung Hoon
    Oh, Sung Yong
    Kang, Jung Hun
    Kim, Kwang Min
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 304 - 304
12345